Enhanced antitumor response mediated by the codelivery of paclitaxel and adenoviral vector expressing IL-12

Molecular Pharmaceutics

Volumn 10, Issue 5, 2013, Pages 1804-1814

  Cao, Linjie ^a   Zeng, Qin ^a   Xu, Chaoqun ^b   Shi, Sanjun ^a   Zhang, Zhirong ^a   Sun, Xun ^a  

^a SICHUAN UNIVERSITY   (China)

^b Sichuan Academy of Chinese Medicine Sciences   (China)

Author keywords

adenovirus; anionic liposomes; co delivery; interleukin 12; melanoma; paclitaxel

Indexed keywords

ADENOVIRUS VECTOR; GAMMA INTERFERON; INTERLEUKIN 12; LIPOSOME; PACLITAXEL; ANTINEOPLASTIC AGENT; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CANCER SURVIVAL; CELL VIABILITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG POTENTIATION; GENETIC TRANSDUCTION; IN VITRO STUDY; IN VIVO STUDY; LUNG CARCINOMA; MELANOMA; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; VIRAL GENE DELIVERY SYSTEM; ZETA POTENTIAL; ADENOVIRIDAE; ANIMAL; BLOOD; C57BL MOUSE; CELL SURVIVAL; DRUG EFFECTS; GENE THERAPY; GENE VECTOR; GENETICS; HUMAN; IMMUNOTHERAPY; MALE; MELANOMA, EXPERIMENTAL; METABOLISM; PATHOLOGY; TUMOR CELL LINE; ULTRASTRUCTURE;

ADENOVIRIDAE; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CELL SURVIVAL; GENETIC THERAPY; GENETIC VECTORS; HUMANS; IMMUNOTHERAPY; INTERFERON-GAMMA; INTERLEUKIN-12; LIPOSOMES; MALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; PACLITAXEL; RECOMBINANT PROTEINS; TRANSDUCTION, GENETIC;

EID: 84877267246     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp300602j     Document Type: Article

References (57)

1. Ramakrishnan, R.; Antonia, S.; Gabrilovich, D. I. Combined modality immunotherapy and chemotherapy: a new perspective Cancer Immunol., Immunother. 2008, 57 (10) 1523-1529
2. Portielje, J. E.; Gratama, J. W.; van Ojik, H. H.; Stoter, G.; Kruit, W. H. IL-12: a promising adjuvant for cancer vaccination Cancer Immunol., Immunother. 2003, 52 (3) 133-144
3. Heufler, C.; Koch, F.; Stanzl, U.; Topar, G.; Wysocka, M.; Trinchieri, G.; Enk, A.; Steinman, R. M.; Romani, N.; Schuler, G. Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-γ production by T helper 1 cells Eur. J. Immunol. 1996, 26 (3) 659-668
4. Del Vecchio, M.; Bajetta, E.; Canova, S.; Lotze, M. T.; Wesa, A.; Parmiani, G.; Anichini, A. Interleukin-12: biological properties and clinical application Clin. Cancer Res. 2007, 13 (16) 4677-4685
5. Brunda, M. J.; Luistro, L.; Warrier, R. R.; Wright, R. B.; Hubbard, B. R.; Murphy, M.; Wolf, S. F.; Gately, M. K. Antitumor and antimetastatic activity of interleukin 12 against murine tumors J. Exp. Med. 1993, 178 (4) 1223-1230
6. Sangro, B.; Melero, I.; Qian, C.; Prieto, J. Gene therapy of cancer based on interleukin 12 Curr. Gene Ther. 2005, 5 (6) 573-581
7. Sangro, B.; Mazzolini, G.; Ruiz, J.; Herraiz, M.; Quiroga, J.; Herrero, I.; Benito, A.; Larrache, J.; Pueyo, J.; Subtil, J. C. Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors J. Clin. Oncol. 2004, 22 (8) 1389-1397
8. Robertson, M. J.; Cameron, C.; Atkins, M. B.; Gordon, M. S.; Lotze, M. T.; Sherman, M. L.; Ritz, J. Immunological effects of interleukin 12 administered by bolus intravenous injection to patients with cancer Clin. Cancer Res. 1999, 5 (1) 9-16
9. Leonard, J. P.; Sherman, M. L.; Fisher, G. L.; Buchanan, L. J.; Larsen, G.; Atkins, M. B.; Sosman, J. A.; Dutcher, J. P.; Vogelzang, N. J.; Ryan, J. L. Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-γ production Blood 1997, 90 (7) 2541-2548
10. Caruso, M.; Pham-Nguyen, K.; Kwong, Y. L.; Xu, B.; Kosai, K. I.; Finegold, M.; Woo, S. L.; Chen, S. H. Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma Proc. Natl. Acad. Sci. 1996, 93 (21) 11302
11. Suzuki, R.; Namai, E.; Oda, Y.; Nishiie, N.; Otake, S.; Koshima, R.; Hirata, K.; Taira, Y.; Utoguchi, N.; Negishi, Y. Cancer gene therapy by IL-12 gene delivery using liposomal bubbles and tumoral ultrasound exposure J. Controlled Release 2010, 142 (2) 245-250
12. Rakhmilevich, A. L.; Turner, J.; Ford, M. J.; McCabe, D.; Sun, W. H.; Sondel, P. M.; Grota, K.; Yang, N. S. Gene gun-mediated skin transfection with interleukin 12 gene results in regression of established primary and metastatic murine tumors Proc. Natl. Acad. Sci. 1996, 93 (13) 6291
13. Tahara, H.; Lotze, M. T.; Robbins, P. D.; Storkus, W. J.; Zitvogel, L. IL-12 Gene Therapy Using Direct Injection of Tumors with Genetically Engineered Autologous Fibroblasts Human Gene Ther. 1995, 6 (12) 1607-1624
14. Gallo, P.; Dharmapuri, S.; Cirpriani, B.; Monaci, P. Adenovirus as vehicle for anticancer genetic immunotherapy Gene Ther. 2005, 12, S84-S91
15. Bramson, J.; Hitt, M.; Gallichan, W. S.; Rosenthal, K. L.; Gauldie, J.; Graham, F. L. Construction of a double recombinant adenovirus vector expressing a heterodimeric cytokine: in vitro and in vivo production of biologically active interleukin-12 Human Gene Ther. 1996, 7 (3) 333-342
16. Bramson, J.; Hitt, M.; Addison, C. L.; Muller, W. J.; Gauldie, J.; Graham, F. L. Direct intratumoral injection of an adenovirus expressing interleukin-12 induces regression and long-lasting immunity that is associated with highly localized expression of interleukin-12 Human Gene Ther. 1996, 7 (16) 1995-2002
17. Bergelson, J. M.; Cunningham, J. A.; Droguett, G.; Kurt-Jones, E. A.; Krithivas, A.; Hong, J. S.; Horwitz, M. S.; Crowell, R. L.; Finberg, R. W. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5 Science 1997, 275 (5304) 1320
18. Li, Y.; Pong, R.-C.; Bergelson, J. M.; Hall, M. C.; Sagalowsky, A. I.; Tseng, C.-P.; Wang, Z.; Hsieh, J.-T. Loss of adenoviral receptor expression in human bladder cancer cells: a potential impact on the efficacy of gene therapy Cancer Res. 1999, 59 (2) 325
19. Kim, M.; Zinn, K. R.; Barnett, B. G.; Sumerel, L. A.; Krasnykh, V.; Curiel, D. T.; Douglas, J. T. The therapeutic efficacy of adenoviral vectors for cancer gene therapy is limited by a low level of primary adenovirus receptors on tumour cells Eur. J. Cancer 2002, 38 (14) 1917-1926
20. Han, S. Y.; Lee, Y.-J.; Jung, H.-I.; Lee, S.-W.; Lim, S.-J.; Hong, S.-H.; Jeong, J.-S. Gene transfer using liposome-complexed adenovirus seems to overcome limitations due to coxsackievirus and adenovirus receptor-deficiency of cancer cells, both in vitro and in vivo Exp. Mol. Med. 2008, 40 (4) 427
21. Wang, L.; Yao, B.; Li, Q.; Mei, K.; Xu, J.-R.; Li, H.-X.; Wang, Y.-S.; Wen, Y.-J.; Wang, X.-D.; Yang, H.-S. Gene Therapy with Recombinant Adenovirus Encoding Endostatin Encapsulated in Cationic Liposome in Coxsackievirus and Adenovirus Receptor-Deficient Colon Carcinoma Murine Models Human Gene Ther. 2011, 22 (9) 1061-1069
22. Ryuke, Y.; Mizuno, M.; Natsume, A.; Yoshida, J. Transduction efficiency of adenoviral vectors into human glioma cells increased by association with cationic liposomes Neurol. Med. Chirurgica 2000, 40 (5) 256-260
23. Audouy, S. A. L.; de Leij, L. F. M. H.; Hoekstra, D.; Molema, G. In vivo characteristics of cationic liposomes as delivery vectors for gene therapy Pharm. Res. 2002, 19 (11) 1599-1605
24. Patil, S. D.; Rhodes, D. G.; Burgess, D. J. Anionic liposomal delivery system for DNA transfection AAPS J. 2004, 6 (4) 13-22
25. Srinivasan, C.; Burgess, D. J. Optimization and characterization of anionic lipoplexes for gene delivery J. Controlled Release 2009, 136 (1) 62-70
26. Patil, S. D.; Rhodes, D. G.; Burgess, D. J. Biophysical characterization of anionic lipoplexes Biochim. Biophys. Acta 2005, 1711 (1) 1-11
27. Zagozdzon, R.; Golab, J.; Stoklosa, T.; Giermasz, A.; Nowicka, D.; Feleszko, W.; Lasek, W.; Jakobisiak, M. Effective chemo-immunotherapy of L1210 leukemia in vivo using interleukin-12 combined with doxorubicin but not with cyclophosphamide, paclitaxel or cisplatin Int. J. Cancer 1998, 77 (5) 720-727
28. Bogdan, C.; Ding, A. Taxol, a microtubule-stabilizing antineoplastic agent, induces expression of tumor necrosis factor alpha and interleukin-1 in macrophages J. Leukocyte Biol. 1992, 52 (1) 119-121
29. Rowinsky, E. K.; Donehower, R. C. Paclitaxel (taxol) N. Engl. J. Med. 1995, 332 (15) 1004
30. Zagozdzon, R.; Stokłosa, T.; Gołab, J.; Giermasz, A.; Lasek, W.; Jakobisiak, M. Augmented antitumor effects of combination therapy with interleukin-12, cisplatin, and tumor necrosis factor-alpha in a murine melanoma model Anticancer Res. 1997, 17 (6D) 4493
31. Sharma, A.; Sharma, U. S.; Straubinger, R. M. Paclitaxel-liposomes for intracavitary therapy of intraperitoneal P388 leukemia Cancer Lett. 1996, 107 (2) 265-272
32. Zhong, Z.; Shi, S.; Han, J.; Zhang, Z.; Sun, X. Anionic liposomes increase the efficiency of adenovirus-mediated gene transfer to coxsackie-adenovirus receptor deficient cells Mol. Pharmaceutics 2009, 7 (1) 105-115
33. Yamashita, M.; Ino, A.; Kawabata, K.; Sakurai, F.; Mizuguchi, H. Expression of coxsackie and adenovirus receptor reduces the lung metastatic potential of murine tumor cells Int. J. Cancer 2007, 121 (8) 1690-1696
34. Gambotto, A.; Tueting, T.; McVey, D. L.; Kovesdi, I.; Tahara, H.; Lotze, M. T.; Robbins, P. D. Induction of antitumor immunity by direct intratumoral injection of a recombinant adenovirus vector expressing interleukin-12 Cancer Gene Ther. 1999, 6 (1) 45
35. Tomayko, M. M.; Reynolds, C. P. Determination of subcutaneous tumor size in athymic (nude) mice Cancer Chemother. Pharmacol. 1989, 24 (3) 148-154
36. Lamont, A. G.; Adorini, L. IL-12: a key cytokine in immune regulation Immunol. Today 1996, 17 (5) 214-217
37. Nastala, C. L.; Edington, H. D.; McKinney, T. G.; Tahara, H.; Nalesnik, M. A.; Brunda, M. J.; Gately, M. K.; Wolf, S. F.; Schreiber, R. D.; Storkus, W. J. Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production J. Immunol. 1994, 153 (4) 1697
38. Kishida, T.; Asada, H.; Itokawa, Y.; Yasutomi, K.; Shin-Ya, M.; Gojo, S.; Cui, F.-D.; Ueda, Y.; Yamagishi, H.; Imanishi, J.; Mazda, O. Electrochemo-gene therapy of cancer: intratumoral delivery of interleukin-12 gene and bleomycin synergistically induced therapeutic immunity and suppressed subcutaneous and metastatic melanomas in mice Mol. Ther. 2003, 8 (5) 738-745
39. Mehrotra, P. T.; Wu, D.; Crim, J. A.; Mostowski, H. S.; Siegel, J. P. Effects of IL-12 on the generation of cytotoxic activity in human CD8+ T lymphocytes J. Immunol. 1993, 151 (5) 2444
40. Cavallo, F.; Di Carlo, E.; Butera, M.; Verrua, R.; Colombo, M. P.; Musiani, P.; Forni, G. Immune events associated with the cure of established tumors and spontaneous metastases by local and systemic interleukin 12 Cancer Res. 1999, 59 (2) 414
41. Trinchieri, G. Interleukin-12 and the regulation of innate resistance and adaptive immunity Nat. Rev. Immunol. 2003, 3 (2) 133-146
42. Kishida, T.; Asada, H.; Satoh, E.; Tanaka, S.; Shinya, M.; Hirai, H.; Iwai, M.; Tahara, H.; Imanishi, J.; Mazda, O. In vivo electroporation-mediated transfer of interleukin-12 and interleukin-18 genes induces significant antitumor effects against melanoma in mice Gene Ther. 2001, 8 (16) 1234-1240
43. Yamashita, Y.; Shimada, M.; Hasegawa, H.; Minagawa, R.; Rikimaru, T.; Hamatsu, T.; Tanaka, S.; Shirabe, K.; Miyazaki, J.-i.; Sugimachi, K. Electroporation-mediated interleukin-12 gene therapy for hepatocellular carcinoma in the mice model Cancer Res. 2001, 61 (3) 1005-1012
44. Tamura, T.; Nishi, T.; Goto, T.; Takeshima, H.; Dev, S. B.; Ushio, Y.; Sakata, T. Intratumoral delivery of interleukin 12 expression plasmids with in vivo electroporation is effective for colon and renal cancer Human Gene Ther. 2001, 12 (10) 1265-1276
45. Chan, S. H.; Perussia, B.; Gupta, J. W.; Kobayashi, M.; Pospisil, M.; Young, H. A.; Wolf, S. W.; Young, D.; Clark, S. C.; Trinchieri, G. Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers J. Exp. Med. 1991, 173 (4) 869-879
46. Cassatella, M. A.; Meda, L.; Gasperini, S.; D'Andrea, A.; Ma, X.; Trinchieri, G. Interleukin-12 production by human polymorphonuclear leukocytes Eur. J. Immunol. 1995, 25 (1) 1-5
47. Pulaski, B. A.; Smyth, M. J.; Ostrand-Rosenberg, S. Interferon-γ- dependent phagocytic cells are a critical component of innate immunity against metastatic mammary carcinoma Cancer Res. 2002, 62 (15) 4406
48. Debrick, J. E.; Campbell, P. A.; Staerz, U. Macrophages as accessory cells for class I MHC-restricted immune responses J. Immunol. 1991, 147 (9) 2846
49. Elgert, K. D.; Alleva, D. G.; Mullins, D. W. Tumor-induced immune dysfunction: the macrophage connection J. Leukocyte Biol. 1998, 64 (3) 275-290
50. Perera, P. Y.; Mayadas, T. N.; Takeuchi, O.; Akira, S.; Zaks-Zilberman, M.; Goyert, S. M.; Vogel, S. N. CD11b/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and taxol-inducible gene expression J. Immunol. 2001, 166 (1) 574
51. Mullins, D. W.; Koci, M. D.; Burger, C. J.; Elgert, K. D. Interleukin-12 overcomes paclitaxel-mediated suppression of T-cell proliferation Immunopharmacol. Immunotoxicol. 1998, 20 (4) 473-492
52. Wang, Y.; Gao, S.; Ye, W.-H.; Yoon, H. S.; Yang, Y.-Y. Co-delivery of drugs and DNA from cationic core-shell nanoparticles self-assembled from a biodegradable copolymer Nat. Mater. 2006, 5 (10) 791-796
53. Son, K.; Huang, L. Factors influencing the drug sensitization of human tumor cells for in situ lipofection Gene Ther. 1996, 3 (7) 630
54. Nair, R. R.; Rodgers, J. R.; Schwarz, L. A. Enhancement of transgene expression by combining glucocorticoids and anti-mitotic agents during transient transfection using DNA-cationic liposomes Mol. Ther. 2002, 5 (4) 455-462
55. Herdeg, C.; Oberhoff, M.; Baumbach, A.; Blattner, A.; Axel, D. I.; Schröder, S.; Heinle, H.; Karsch, K. R. Local paclitaxel delivery for the prevention of restenosis: biological effects and efficacy in vivo J. Am. Coll. Cardiol. 2000, 35 (7) 1969-1976
56. Janat-Amsbury, M. M.; Yockman, J. W.; Lee, M.; Kern, S.; Furgeson, D. Y.; Bikram, M.; Kim, S. W. Local, non-viral IL-12 gene therapy using a water soluble lipopolymer as carrier system combined with systemic paclitaxel for cancer treatment J. Controlled Release 2005, 101 (1-3) 273-285
57. Wong, H. L.; Shen, Z.; Lu, Z.; Wientjes, M. G.; Au, J. L.-S. Paclitaxel tumor-priming enhances siRNA delivery and transfection in 3-dimensional tumor cultures Mol. Pharmaceutics 2011, 8, 833-840